S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Agenus (AGEN) News Today

$0.66
-0.01 (-1.49%)
(As of 03/1/2024 ET)
SourceHeadline
marketbeat.com logoAgenus Inc. (NASDAQ:AGEN) Shares Sold by Oracle Investment Management Inc.
marketbeat.com - March 1 at 11:48 AM
finance.yahoo.com logoAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
finance.yahoo.com - February 29 at 7:41 AM
finance.yahoo.com logoAgenus Inc. (AGEN) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - February 28 at 12:11 AM
seekingalpha.com logoAgenus: A Would-Be Rockstar Held Back By Middling Financials
seekingalpha.com - February 27 at 9:09 AM
businesswire.com logoAgenus to Participate in Leerink Partners Global Biopharma Conference
businesswire.com - February 26 at 7:30 AM
finance.yahoo.com logoFavourable Signals For Agenus: Numerous Insiders Acquired Stock
finance.yahoo.com - February 19 at 8:32 AM
fool.com logoWhy Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
fool.com - February 15 at 7:53 PM
fool.com logoWhy Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
fool.com - February 15 at 6:38 PM
msn.com logoGinkgo, Agenus win $31M contract to research adjuvants
msn.com - February 15 at 2:50 PM
finance.yahoo.com logoGinkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
finance.yahoo.com - February 15 at 9:47 AM
prnewswire.com logoGinkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
prnewswire.com - February 15 at 7:02 AM
finance.yahoo.com logo7 Analyst-Backed Stocks With Promising 10-Bagger Potential
finance.yahoo.com - February 9 at 5:02 AM
msn.com logoAgenus Advances in BMS Partnership with Clinical Trial Milestone
msn.com - February 1 at 3:42 PM
finance.yahoo.com logoAgenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - January 31 at 12:54 PM
marketbeat.com logoAgenus Inc. (NASDAQ:AGEN) Short Interest Up 5.6% in January
marketbeat.com - January 31 at 4:54 AM
seekingalpha.com logoAgenus: Taking Advantage Of The Risk-Reward Opportunity
seekingalpha.com - January 26 at 7:41 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
markets.businessinsider.com - January 26 at 2:57 AM
markets.businessinsider.com logoAgenus' Botensilimab Study Shows Unprecedented Tumor Shrinkage
markets.businessinsider.com - January 22 at 3:44 PM
msn.com logoAgenus stock up 7% on positive data for colorectal cancer drugs
msn.com - January 22 at 3:44 PM
finance.yahoo.com logoBotensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
finance.yahoo.com - January 22 at 10:43 AM
seekingalpha.com logoAgenus: 2024 May Finally Be The Year For A Major Turnaround
seekingalpha.com - January 18 at 10:43 AM
finance.yahoo.com logoInstitutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses
finance.yahoo.com - January 16 at 8:46 AM
finance.yahoo.com logoAgenus to Participate in B. Riley Healthcare Conference
finance.yahoo.com - January 4 at 9:36 AM
finance.yahoo.com logoBotensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
finance.yahoo.com - December 20 at 9:58 AM
markets.businessinsider.com logoAgenus To Receive Milestone Payment From Bristol Myers Squibb - Quick Facts
markets.businessinsider.com - December 11 at 9:42 AM
finance.yahoo.com logoAgenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
finance.yahoo.com - December 11 at 9:42 AM
finance.yahoo.com logoDr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS
finance.yahoo.com - December 7 at 9:34 AM
finance.yahoo.com logoAgenus (NASDAQ:AGEN) adds US$36m to market cap in the past 7 days, though investors from three years ago are still down 75%
finance.yahoo.com - December 6 at 8:26 AM
finance.yahoo.com logoAvita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance
finance.yahoo.com - November 22 at 10:26 AM
money.usnews.com logoAgenus Inc
money.usnews.com - November 18 at 2:58 PM
finance.yahoo.com logoRainbows and Unicorns: Agenus Inc. (NASDAQ:AGEN) Analysts Just Became A Lot More Optimistic
finance.yahoo.com - November 9 at 7:50 AM
markets.businessinsider.com logoPositive Outlook for Agenus: Promising Clinical Progress and Effective Financial Management Drive Buy Rating
markets.businessinsider.com - November 9 at 1:54 AM
markets.businessinsider.com logoUpwork Reports Third Quarter 2023 Financial Results
markets.businessinsider.com - November 7 at 6:52 PM
msn.com logoAgenus GAAP EPS of -$0.16 beats by $0.04, revenue of $24.31M misses by $0.86M
msn.com - November 7 at 8:51 AM
finance.yahoo.com logoAgenus Reports Third Quarter 2023 Results
finance.yahoo.com - November 7 at 8:51 AM
finance.yahoo.com logoAgenus Inc (AGEN) Reports Q3 2023 Results: Revenue of $24.3 Million and Net Loss of $64.5 Million
finance.yahoo.com - November 7 at 8:51 AM
benzinga.com logoAgenus's Earnings Outlook
benzinga.com - November 6 at 7:40 PM
markets.businessinsider.com logoWhat Wall Street expects from Agenus's earnings
markets.businessinsider.com - November 6 at 7:40 PM
msn.com logoAgenus Q3 2023 Earnings Preview
msn.com - November 6 at 2:39 PM
finance.yahoo.com logoAgenus to Provide Third Quarter 2023 Financial Report and Corporate Update
finance.yahoo.com - October 26 at 10:30 AM
markets.businessinsider.com logoTextainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
markets.businessinsider.com - October 23 at 9:25 AM
finance.yahoo.com logoAgenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
finance.yahoo.com - October 22 at 1:17 PM
stockhouse.com logoESMO 2023: Agenus' Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
stockhouse.com - October 21 at 9:06 AM
finance.yahoo.com logoESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
finance.yahoo.com - October 21 at 9:06 AM
msn.com logoAgenus concludes enrolment in trial to treat colorectal cancer
msn.com - October 11 at 2:12 PM
finance.yahoo.com logoAgenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer
finance.yahoo.com - October 10 at 9:43 AM
msn.com logoAgenus: Getting The Tough Decisions Right With Catalysts Ahead
msn.com - October 6 at 8:45 PM
finance.yahoo.com logoAgenus To Host BOT/BAL Program Update at ESMO 2023
finance.yahoo.com - October 5 at 8:04 AM
msn.com logoNew Drug Combo Shows Promising Results Against Early Stages Of Colorectal Cancer
msn.com - September 20 at 8:53 PM
marketbeat.com logoAgenus Inc. (NASDAQ:AGEN) Receives Average Rating of "Buy" from Brokerages
marketbeat.com - September 20 at 2:19 AM
Get Agenus News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter.



AGEN Media Mentions By Week

AGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGEN
News Sentiment

0.82

0.65

Average
Medical
News Sentiment

AGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGEN Articles
This Week

6

2

AGEN Articles
Average Week

Get Agenus News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AGEN) was last updated on 3/3/2024 by MarketBeat.com Staff